Skip to content

Faecal Microbiota Analysis in Neurotypical and Autism Syndrome Disorder Siblings

Faecal Microbiota Analysis in Neurotypical and Autism Syndrome Disorder Siblings: FAMILY

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05794620
Acronym
FAMILY
Enrollment
20
Registered
2023-04-03
Start date
2022-12-20
Completion date
2024-04-12
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism, Autism Spectrum Disorder

Brief summary

This study aims to accurately characterise the gut microbiota composition of faeces of children with ASD and compare it with the gut microbiota composition of their neurotypical siblings. In addition it aims to also characterise the metagenome and metabolome of the faeces of both ASD and neurotypical siblings.

Interventions

OTHERStool sample

Stool sample

Sponsors

East Suffolk and North Essex NHS Foundation Trust
Lead SponsorOTHER
Quadram Institute Bioscience
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* Children of both sexes who are diagnosed with ASD and under the care of ESNEFT who have a neurotypical sibling (either full or half sibling), who share their living environment. This is due to the study requiring stool samples that are from siblings, to control for genes and environment where possible. * Aged 3 years to 10 years old (at time of consent) * Parent/guardian able to consent to participate * Parent/guardian able to complete required surveys (or with accommodated adjustments)

Exclusion criteria

* Use of antibiotics in the previous 4 weeks * Not under the care of ESNEFT * Children \<3 years old and \>10 years old * Children that don't have half or full siblings * Parent/guardian unable to provide informed consent or complete surveys, despite reasonable adjustments being implemented

Design outcomes

Primary

MeasureTime frameDescription
Gut microbiota0 weeksGut microbiota composition of faeces of children with ASD

Countries

United Kingdom

Contacts

PRINCIPAL_INVESTIGATORBen Marlow

East Suffolk and North Essex NHS Foundation Trust

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026